Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Other-Current-Liabilities" stands at 13.16 Billion Hong Kong Dollars as of 06/30/2025, the highest value since 09/30/2023.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Other Current Liabilities" stands at 13.16 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.68 percent compared to the value the year prior.
The 1 year change in percent is 25.68.
The 3 year change in percent is 46.67.
The 5 year change in percent is 78.08.
The 10 year change in percent is 317.85.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Current Liabilities | 280,205,508,085.11 |